HEADER TRANSFERASE 20-JUN-13 4BUI TITLE CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH METHYL 4-(4- TITLE 2 OXO-3,4-DIHYDROQUINAZOLIN-2-YL)BENZOATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TANKYRASE-2; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: C-TERMINAL FRAGMENT, RESIDUES 946-1162; COMPND 5 SYNONYM: TANK2, ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 6, COMPND 6 ARTD6, POLY [ADP-RIBOSE] POLYMERASE 5B, TNKS-2, TRF1-INTERACTING COMPND 7 ANKYRIN-RELATED ADP-RIBOSE POLYMERASE 2, TANKYRASE II, TANKYRASE-LIKE COMPND 8 PROTEIN, TANKYRASE-RELATED PROTEIN; COMPND 9 EC: 2.4.2.30; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: ROSETTA 2; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PNIC28-BSA4 KEYWDS TRANSFERASE, PROTEIN-LIGAND COMPLEX, DIPHTHERIA TOXIN LIKE FOLD, ADP- KEYWDS 2 RIBOSYLATION, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.HAIKARAINEN,M.NARWAL,L.LEHTIO REVDAT 5 20-DEC-23 4BUI 1 REMARK REVDAT 4 06-FEB-19 4BUI 1 REMARK REVDAT 3 30-JAN-19 4BUI 1 REMARK REVDAT 2 11-DEC-13 4BUI 1 JRNL REVDAT 1 30-OCT-13 4BUI 0 JRNL AUTH T.HAIKARAINEN,J.KOIVUNEN,M.NARWAL,H.VENKANNAGARI,E.OBAJI, JRNL AUTH 2 P.JOENSUU,T.PIHLAJANIEMI,L.LEHTIO JRNL TITL PARA-SUBSTITUTED 2-PHENYL-3,4-DIHYDROQUINAZOLIN-4-ONES AS JRNL TITL 2 POTENT AND SELECTIVE TANKYRASE INHIBITORS. JRNL REF CHEMMEDCHEM V. 8 1978 2013 JRNL REFN ISSN 1860-7179 JRNL PMID 24130191 JRNL DOI 10.1002/CMDC.201300337 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0029 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.45 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 36826 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.166 REMARK 3 R VALUE (WORKING SET) : 0.164 REMARK 3 FREE R VALUE : 0.202 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1939 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.00 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2673 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.54 REMARK 3 BIN R VALUE (WORKING SET) : 0.2250 REMARK 3 BIN FREE R VALUE SET COUNT : 141 REMARK 3 BIN FREE R VALUE : 0.2940 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3347 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 76 REMARK 3 SOLVENT ATOMS : 398 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.58 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.12000 REMARK 3 B22 (A**2) : -1.08000 REMARK 3 B33 (A**2) : 0.96000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.138 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.130 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.084 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.965 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.959 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.941 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3529 ; 0.012 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3230 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4756 ; 1.491 ; 1.952 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7413 ; 0.765 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 421 ; 6.227 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 182 ;33.407 ;22.857 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 582 ;13.405 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 29 ;18.190 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 473 ; 0.089 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4036 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 919 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 4BUI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-JUN-13. REMARK 100 THE DEPOSITION ID IS D_1290057377. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-SEP-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.93340 REMARK 200 MONOCHROMATOR : DIAMOND (001) REMARK 200 OPTICS : VERTICALLY BENDED MULTILAYER REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38766 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.1400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.60000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.410 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 3KR7 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.44 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M LISO4, 0.1 M TRIS HCL, 22% REMARK 280 PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 59.57000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 59.57000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 45.68500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 48.90000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 45.68500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 48.90000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 59.57000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 45.68500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 48.90000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 59.57000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 45.68500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 48.90000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 923 REMARK 465 HIS A 924 REMARK 465 HIS A 925 REMARK 465 HIS A 926 REMARK 465 HIS A 927 REMARK 465 HIS A 928 REMARK 465 HIS A 929 REMARK 465 SER A 930 REMARK 465 SER A 931 REMARK 465 GLY A 932 REMARK 465 VAL A 933 REMARK 465 ASP A 934 REMARK 465 LEU A 935 REMARK 465 GLY A 936 REMARK 465 THR A 937 REMARK 465 GLU A 938 REMARK 465 ASN A 939 REMARK 465 LEU A 940 REMARK 465 TYR A 941 REMARK 465 PHE A 942 REMARK 465 GLN A 943 REMARK 465 SER A 944 REMARK 465 MET A 945 REMARK 465 LEU A 946 REMARK 465 ASN A 947 REMARK 465 THR A 948 REMARK 465 SER A 949 REMARK 465 GLY A 950 REMARK 465 SER A 951 REMARK 465 MET A 1113 REMARK 465 LYS A 1114 REMARK 465 GLY A 1162 REMARK 465 MET C 923 REMARK 465 HIS C 924 REMARK 465 HIS C 925 REMARK 465 HIS C 926 REMARK 465 HIS C 927 REMARK 465 HIS C 928 REMARK 465 HIS C 929 REMARK 465 SER C 930 REMARK 465 SER C 931 REMARK 465 GLY C 932 REMARK 465 VAL C 933 REMARK 465 ASP C 934 REMARK 465 LEU C 935 REMARK 465 GLY C 936 REMARK 465 THR C 937 REMARK 465 GLU C 938 REMARK 465 ASN C 939 REMARK 465 LEU C 940 REMARK 465 TYR C 941 REMARK 465 PHE C 942 REMARK 465 GLN C 943 REMARK 465 SER C 944 REMARK 465 MET C 945 REMARK 465 LEU C 946 REMARK 465 ASN C 947 REMARK 465 THR C 948 REMARK 465 SER C 949 REMARK 465 GLY C 950 REMARK 465 SER C 951 REMARK 465 GLY C 1162 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS C1114 CA C O CB CG CD CE REMARK 470 LYS C1114 NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG C1008 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A1020 55.80 -144.24 REMARK 500 VAL A1131 -57.60 -140.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 2162 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN C 2162 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 2163 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 2163 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 2164 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 2164 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 2165 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE W2E A 2166 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE W2E C 2165 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL C 2166 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4BU3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 2-PHENYL-3,4- REMARK 900 DIHYDROQUINAZOLIN-4-ONE REMARK 900 RELATED ID: 4BU5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 2-(4- REMARK 900 HYDROXYPHENYL)-3,4-DIHYDROQUINAZOLIN-4-ONE REMARK 900 RELATED ID: 4BU6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 2-(4- REMARK 900 AMINOPHENYL)-3,4-DIHYDROQUINAZOLIN-4-ONE REMARK 900 RELATED ID: 4BU7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 2-(4- REMARK 900 BROMOPHENYL)-3,4-DIHYDROQUINAZOLIN-4-ONE REMARK 900 RELATED ID: 4BU8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 4-(4-OXO-1,4- REMARK 900 DIHYDROQUINAZOLIN-2-YL)BENZONITRILE REMARK 900 RELATED ID: 4BU9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 2-(4- REMARK 900 METHOXYPHENYL)-3,4-DIHYDROQUINAZOLIN-4-ONE REMARK 900 RELATED ID: 4BUA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 2-(4- REMARK 900 (METHYLSULFANYL)PHENYL)-3,4-DIHYDROQUINAZOLIN-4- ONE REMARK 900 RELATED ID: 4BUD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 2-(4-TERT- REMARK 900 BUTYLPHENYL)-1,4-DIHYDROQUINAZOLIN-4-ONE REMARK 900 RELATED ID: 4BUE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 3-METHYL-N- REMARK 900 (4-(4-OXO-3,4-DIHYDROQUINAZOLIN-2-YL) PHENYL)BUTANAMIDE REMARK 900 RELATED ID: 4BUF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 2-(4- REMARK 900 ACETYLPHENYL)-3,4-DIHYDROQUINAZOLIN-4-ONE REMARK 900 RELATED ID: 4BUS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 2-(4-(4-OXO- REMARK 900 3,4-DIHYDROQUINAZOLIN-2-YL)PHENOXY) ACETIC ACID REMARK 900 RELATED ID: 4BUT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 4-(4-OXO-3,4- REMARK 900 DIHYDROQUINAZOLIN-2-YL)BENZENE-1- SULFONAMIDE REMARK 900 RELATED ID: 4BUU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH (4-(4-OXO-3, REMARK 900 4-DIHYDROQUINAZOLIN-2-YL)PHENYL) METHANESULFONAMIDE REMARK 900 RELATED ID: 4BUV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH N-(4-(4-OXO- REMARK 900 3,4-DIHYDROQUINAZOLIN-2-YL)PHENYL) THIOPHENE-2-CARBOXAMIDE REMARK 900 RELATED ID: 4BUW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 2-(4-(2-OXO- REMARK 900 1,3-OXAZOLIDIN-3-YL)PHENYL)-3,4- DIHYDROQUINAZOLIN-4-ONE REMARK 900 RELATED ID: 4BUX RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 3-((4-(4-OXO- REMARK 900 3,4-DIHYDROQUINAZOLIN-2-YL)PHENYL) METHYL)IMIDAZOLIDINE-2,4-DIONE REMARK 900 RELATED ID: 4BUY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 5-METHYL-5- REMARK 900 (4-(4-OXO-3,4-DIHYDROQUINAZOLIN-2-YL) PHENYL)IMIDAZOLIDINE-2,4-DIONE DBREF 4BUI A 946 1162 UNP Q9H2K2 TNKS2_HUMAN 946 1162 DBREF 4BUI C 946 1162 UNP Q9H2K2 TNKS2_HUMAN 946 1162 SEQADV 4BUI MET A 923 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI HIS A 924 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI HIS A 925 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI HIS A 926 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI HIS A 927 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI HIS A 928 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI HIS A 929 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI SER A 930 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI SER A 931 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI GLY A 932 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI VAL A 933 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI ASP A 934 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI LEU A 935 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI GLY A 936 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI THR A 937 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI GLU A 938 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI ASN A 939 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI LEU A 940 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI TYR A 941 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI PHE A 942 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI GLN A 943 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI SER A 944 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI MET A 945 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI MET C 923 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI HIS C 924 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI HIS C 925 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI HIS C 926 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI HIS C 927 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI HIS C 928 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI HIS C 929 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI SER C 930 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI SER C 931 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI GLY C 932 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI VAL C 933 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI ASP C 934 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI LEU C 935 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI GLY C 936 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI THR C 937 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI GLU C 938 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI ASN C 939 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI LEU C 940 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI TYR C 941 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI PHE C 942 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI GLN C 943 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI SER C 944 UNP Q9H2K2 EXPRESSION TAG SEQADV 4BUI MET C 945 UNP Q9H2K2 EXPRESSION TAG SEQRES 1 A 240 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 240 GLY THR GLU ASN LEU TYR PHE GLN SER MET LEU ASN THR SEQRES 3 A 240 SER GLY SER GLY THR ILE LEU ILE ASP LEU SER PRO ASP SEQRES 4 A 240 ASP LYS GLU PHE GLN SER VAL GLU GLU GLU MET GLN SER SEQRES 5 A 240 THR VAL ARG GLU HIS ARG ASP GLY GLY HIS ALA GLY GLY SEQRES 6 A 240 ILE PHE ASN ARG TYR ASN ILE LEU LYS ILE GLN LYS VAL SEQRES 7 A 240 CYS ASN LYS LYS LEU TRP GLU ARG TYR THR HIS ARG ARG SEQRES 8 A 240 LYS GLU VAL SER GLU GLU ASN HIS ASN HIS ALA ASN GLU SEQRES 9 A 240 ARG MET LEU PHE HIS GLY SER PRO PHE VAL ASN ALA ILE SEQRES 10 A 240 ILE HIS LYS GLY PHE ASP GLU ARG HIS ALA TYR ILE GLY SEQRES 11 A 240 GLY MET PHE GLY ALA GLY ILE TYR PHE ALA GLU ASN SER SEQRES 12 A 240 SER LYS SER ASN GLN TYR VAL TYR GLY ILE GLY GLY GLY SEQRES 13 A 240 THR GLY CYS PRO VAL HIS LYS ASP ARG SER CYS TYR ILE SEQRES 14 A 240 CYS HIS ARG GLN LEU LEU PHE CYS ARG VAL THR LEU GLY SEQRES 15 A 240 LYS SER PHE LEU GLN PHE SER ALA MET LYS MET ALA HIS SEQRES 16 A 240 SER PRO PRO GLY HIS HIS SER VAL THR GLY ARG PRO SER SEQRES 17 A 240 VAL ASN GLY LEU ALA LEU ALA GLU TYR VAL ILE TYR ARG SEQRES 18 A 240 GLY GLU GLN ALA TYR PRO GLU TYR LEU ILE THR TYR GLN SEQRES 19 A 240 ILE MET ARG PRO GLU GLY SEQRES 1 C 240 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 C 240 GLY THR GLU ASN LEU TYR PHE GLN SER MET LEU ASN THR SEQRES 3 C 240 SER GLY SER GLY THR ILE LEU ILE ASP LEU SER PRO ASP SEQRES 4 C 240 ASP LYS GLU PHE GLN SER VAL GLU GLU GLU MET GLN SER SEQRES 5 C 240 THR VAL ARG GLU HIS ARG ASP GLY GLY HIS ALA GLY GLY SEQRES 6 C 240 ILE PHE ASN ARG TYR ASN ILE LEU LYS ILE GLN LYS VAL SEQRES 7 C 240 CYS ASN LYS LYS LEU TRP GLU ARG TYR THR HIS ARG ARG SEQRES 8 C 240 LYS GLU VAL SER GLU GLU ASN HIS ASN HIS ALA ASN GLU SEQRES 9 C 240 ARG MET LEU PHE HIS GLY SER PRO PHE VAL ASN ALA ILE SEQRES 10 C 240 ILE HIS LYS GLY PHE ASP GLU ARG HIS ALA TYR ILE GLY SEQRES 11 C 240 GLY MET PHE GLY ALA GLY ILE TYR PHE ALA GLU ASN SER SEQRES 12 C 240 SER LYS SER ASN GLN TYR VAL TYR GLY ILE GLY GLY GLY SEQRES 13 C 240 THR GLY CYS PRO VAL HIS LYS ASP ARG SER CYS TYR ILE SEQRES 14 C 240 CYS HIS ARG GLN LEU LEU PHE CYS ARG VAL THR LEU GLY SEQRES 15 C 240 LYS SER PHE LEU GLN PHE SER ALA MET LYS MET ALA HIS SEQRES 16 C 240 SER PRO PRO GLY HIS HIS SER VAL THR GLY ARG PRO SER SEQRES 17 C 240 VAL ASN GLY LEU ALA LEU ALA GLU TYR VAL ILE TYR ARG SEQRES 18 C 240 GLY GLU GLN ALA TYR PRO GLU TYR LEU ILE THR TYR GLN SEQRES 19 C 240 ILE MET ARG PRO GLU GLY HET ZN A2162 1 HET SO4 A2163 5 HET SO4 A2164 5 HET GOL A2165 6 HET W2E A2166 21 HET ZN C2162 1 HET SO4 C2163 5 HET SO4 C2164 5 HET W2E C2165 21 HET GOL C2166 6 HETNAM ZN ZINC ION HETNAM SO4 SULFATE ION HETNAM GOL GLYCEROL HETNAM W2E METHYL 4-(4-OXO-3,4-DIHYDROQUINAZOLIN-2-YL)BENZOATE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 ZN 2(ZN 2+) FORMUL 4 SO4 4(O4 S 2-) FORMUL 6 GOL 2(C3 H8 O3) FORMUL 7 W2E 2(C16 H12 N2 O3) FORMUL 13 HOH *398(H2 O) HELIX 1 1 ASP A 962 THR A 975 1 14 HELIX 2 2 ASN A 1002 GLU A 1019 1 18 HELIX 3 3 PHE A 1035 GLY A 1043 1 9 HELIX 4 4 ASP A 1045 ALA A 1049 5 5 HELIX 5 5 ASN A 1064 GLN A 1070 1 7 HELIX 6 6 GLY A 1074 GLY A 1078 5 5 HELIX 7 7 ARG A 1143 GLU A 1145 5 3 HELIX 8 8 ASP C 962 THR C 975 1 14 HELIX 9 9 ASN C 1002 ASN C 1020 1 19 HELIX 10 10 PHE C 1035 GLY C 1043 1 9 HELIX 11 11 ASP C 1045 ALA C 1049 5 5 HELIX 12 12 ASN C 1064 GLN C 1070 1 7 HELIX 13 13 GLY C 1074 GLY C 1078 5 5 HELIX 14 14 ARG C 1143 GLU C 1145 5 3 SHEET 1 AA 5 ILE A 954 ASP A 957 0 SHEET 2 AA 5 TYR A 992 CYS A1001 -1 O LYS A 999 N ILE A 956 SHEET 3 AA 5 ALA A1147 ILE A1157 -1 O GLU A1150 N VAL A1000 SHEET 4 AA 5 ARG A1094 THR A1102 -1 O ARG A1094 N TYR A1155 SHEET 5 AA 5 GLU A1026 HIS A1031 -1 O ARG A1027 N VAL A1101 SHEET 1 AB 4 ILE A1059 ALA A1062 0 SHEET 2 AB 4 GLU A1138 ILE A1141 -1 O TYR A1139 N PHE A1061 SHEET 3 AB 4 SER A1124 PRO A1129 -1 O VAL A1125 N VAL A1140 SHEET 4 AB 4 SER A1106 SER A1111 1 O PHE A1107 N THR A1126 SHEET 1 CA 5 ILE C 954 ASP C 957 0 SHEET 2 CA 5 TYR C 992 CYS C1001 -1 O LYS C 999 N ILE C 956 SHEET 3 CA 5 ALA C1147 ILE C1157 -1 O GLU C1150 N VAL C1000 SHEET 4 CA 5 ARG C1094 THR C1102 -1 O ARG C1094 N TYR C1155 SHEET 5 CA 5 GLU C1026 HIS C1031 -1 O ARG C1027 N VAL C1101 SHEET 1 CB 4 ILE C1059 ALA C1062 0 SHEET 2 CB 4 GLU C1138 ILE C1141 -1 O TYR C1139 N PHE C1061 SHEET 3 CB 4 SER C1124 PRO C1129 -1 O VAL C1125 N VAL C1140 SHEET 4 CB 4 SER C1106 SER C1111 1 O PHE C1107 N THR C1126 SITE 1 AC1 4 CYS A1081 HIS A1084 CYS A1089 CYS A1092 SITE 1 AC2 4 CYS C1081 HIS C1084 CYS C1089 CYS C1092 SITE 1 AC3 8 ARG A 977 HIS A 979 ARG A 980 LYS A1067 SITE 2 AC3 8 GLN A1070 HOH A3042 HOH A3141 HOH A3205 SITE 1 AC4 6 ARG C 977 HIS C 979 ARG C 980 LYS C1067 SITE 2 AC4 6 GLN C1070 HOH C3038 SITE 1 AC5 5 ASN C 990 ARG C 991 PRO C1160 GLU C1161 SITE 2 AC5 5 HOH C3052 SITE 1 AC6 6 ASN A 990 ARG A 991 PRO A1160 GLU A1161 SITE 2 AC6 6 HOH A3057 HOH A3060 SITE 1 AC7 5 PRO A1129 SER A1130 VAL A1131 ASN A1132 SITE 2 AC7 5 GLY A1133 SITE 1 AC8 13 HIS A1031 GLY A1032 PHE A1035 ARG A1047 SITE 2 AC8 13 ALA A1049 TYR A1050 TYR A1060 LYS A1067 SITE 3 AC8 13 SER A1068 TYR A1071 ILE A1075 GLU A1138 SITE 4 AC8 13 HOH A3115 SITE 1 AC9 14 HIS C1031 GLY C1032 PHE C1035 ARG C1047 SITE 2 AC9 14 HIS C1048 ALA C1049 TYR C1050 TYR C1060 SITE 3 AC9 14 LYS C1067 SER C1068 TYR C1071 ILE C1075 SITE 4 AC9 14 GLU C1138 HOH C3101 SITE 1 BC1 10 GLU C 978 HIS C 979 GLY C 982 GLY C 983 SITE 2 BC1 10 GLY C 987 ILE C 988 PHE C 989 HOH C3033 SITE 3 BC1 10 HOH C3037 HOH C3051 CRYST1 91.370 97.800 119.140 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010945 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010225 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008393 0.00000